Key facts
- DocStation’s last known valuation is $24.5M (Nov 2023).
- It has raised $10.0M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Alumni Ventures, Techstars, Right Side Capital Management, 8VC, Tech Square Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for DocStation
- ·The full record, as it builds
Funding rounds
No funding rounds for DocStation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DocStation
Operator of a patient care platform intended to connect payers and pharmacists for decreased health costs and improved patient outcomes. The company's platform integrates a dashboard for maintaining current diagnoses, medications, immunizations, allergies and adverse events, creates care plans and goals, monitors adherence and schedules follow-ups all in one place, enabling pharmacists to provide value-based care for their patients by being connected to them in real-time.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2017
- Employees
- 24
- Website
- docstation.co/
- Ownership
- Privately Held (backing)
DocStation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DocStation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DocStation in its N-PORT filings yet. We sweep new filings monthly.